Nuo Therapeutics, Inc.
AURX
$1.52
-$0.02-1.30%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 1.62M | 1.37M | 1.17M | 1.03M | 782.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.62M | 1.37M | 1.17M | 1.03M | 782.00K |
| Cost of Revenue | 373.20K | 302.80K | 257.80K | 211.10K | 166.30K |
| Gross Profit | 1.24M | 1.06M | 909.40K | 817.40K | 615.70K |
| SG&A Expenses | 3.74M | 3.52M | 3.39M | 3.51M | 3.64M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.11M | 3.82M | 3.65M | 3.72M | 3.80M |
| Operating Income | -2.49M | -2.46M | -2.48M | -2.69M | -3.02M |
| Income Before Tax | -2.36M | -2.32M | -2.48M | -2.69M | -3.02M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.36 | -2.32 | -2.48 | -2.69 | -3.02 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.36M | -2.32M | -2.48M | -2.69M | -3.02M |
| EBIT | -2.49M | -2.46M | -2.48M | -2.69M | -3.02M |
| EBITDA | -2.46M | -2.43M | -2.47M | -2.68M | -3.01M |
| EPS Basic | -0.05 | -0.05 | -0.06 | -0.06 | -0.07 |
| Normalized Basic EPS | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
| EPS Diluted | -0.05 | -0.05 | -0.06 | -0.06 | -0.07 |
| Normalized Diluted EPS | -0.03 | -0.03 | -0.04 | -0.04 | -0.04 |
| Average Basic Shares Outstanding | 184.26M | 181.69M | 177.08M | 173.61M | 170.75M |
| Average Diluted Shares Outstanding | 184.26M | 181.69M | 177.08M | 173.61M | 170.75M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |